Skip to main content
Clinical Trials/CTRI/2019/03/018013
CTRI/2019/03/018013CompletedPhase 4

Clinical study on Amrita Gugglu and Sudarshan Churna Tablet in the management of Post-Chikungunya Chronic Inflammatory Arthritis - An open randomized comparative trial

Institute for Post Graduate Teaching and Research in Ayurveda0 sites69 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor
Enrollment
69

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Patients having symptoms of Post-Chikungunya chronic inflammatory arthritis with history of Chikungunya fever will be selected from OPD and IPD of IPGT and RA Hospital, Jamnagar.

Exclusion Criteria

  • Age less than 18 years more than 70 years.
  • Patients having previous Rheumatological diseases, Gout, Psoriatic arthritis, fibromyalgia and SLE etc.
  • Pregnant and lactating women.
  • Other chronic debilitating disease like STD, tuberculosis, hypertension and carcinoma etc.

Investigators

Sponsor
Institute for Post Graduate Teaching and Research in Ayurveda

Similar Trials